After developing its data pooling service for Canadian banks, CanDeal has now launched a data and analytics unit, DNA, for OTC derivatives pricing. We talked to executive vice president of DNA, Andre Craig, about results so far and how repo is expected to fit in.
This content requires free registration (unlocked content) or a Finadium subscription. Log in or get access today by signing up here.
